Literature DB >> 17380234

Clinical and therapeutic variables influencing hospitalisation for bronchiolitis in a community-based paediatric group practice.

Baha Al-Shawwa1, Nidal Al-Huniti, Miles Weinberger, Mutasim Abu-Hasan.   

Abstract

AIM: To examine the effect of different clinical characteristics and different treatments on the hospitalisation of infants with bronchiolitis seen in an outpatient clinic setting.
METHODS: The medical records of infants under 2 years of age who presented with a first episode of wheezing over a two-year period were reviewed retrospectively. Hospitalisation within ten days of evaluation was used as the primary outcome measure.
RESULTS: Data from 320 patients were included. 17% were hospitalised. Age was lower in the hospitalised patients (4.9 months vs. 7.1, p<0.001). Hospitalisation was higher in RSV-positive versus RSV-negative patients (38% vs. 10%, p<0.001) and was higher in those children who had been exposed to tobacco smoke versus those who hadn't (24% vs. 12%, p<0.01). Treatment with oral corticosteroids was associated with fewer hospitalisations in those patients with a family history of asthma or allergic rhinitis (9.7% vs. 24%, p=0.02) and in RSV-negative patients (2.5% vs. 16.7%, p<0.05).
CONCLUSION: Early treatment of bronchiolitis with oral corticosteroid in an outpatient clinic setting was associated with lower hospitalisation rates in patients with a family history of asthma or allergic rhinitis and in RSV-negative patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17380234      PMCID: PMC6634188          DOI: 10.3132/pcrj.2007.00018

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  2 in total

Review 1.  The impact of viral bronchiolitis phenotyping: Is it time to consider phenotype-specific responses to individualize pharmacological management?

Authors:  Carlos E Rodríguez-Martínez; Jose A Castro-Rodriguez; Gustavo Nino; Fabio Midulla
Journal:  Paediatr Respir Rev       Date:  2019-04-12       Impact factor: 2.726

2.  Cost-effectiveness analysis of phenotypic-guided versus guidelines-guided bronchodilator therapy in viral bronchiolitis.

Authors:  Carlos E Rodriguez-Martinez; Gustavo Nino; Jose A Castro-Rodriguez; Geovanny F Perez; Monica P Sossa-Briceño; Jefferson A Buendia
Journal:  Pediatr Pulmonol       Date:  2020-10-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.